Prothena Corp Public (PRTA) EBITDA Margin Growth (3y) (2016 - 2026)
Prothena Corp Public (PRTA) EBITDA Margin Growth (3y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-40,178.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
530.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Prothena Corp Public |
479.08 Mn |
149.61 Mn |
- |
265,561.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
265,561.00 |
| Dec 31, 2025 |
-11.53 Mn |
| Sep 30, 2025 |
165,161.00 |
| Jun 30, 2025 |
137,898.00 |
| Mar 31, 2025 |
97,190.00 |
| Dec 31, 2024 |
-23,330.00 |
| Sep 30, 2024 |
-693,549.00 |
| Jun 30, 2024 |
-231.00 |
| Mar 31, 2024 |
-14.30 Mn |
| Dec 31, 2023 |
-1.64 Mn |
| Sep 30, 2023 |
1.97 Mn |
| Jun 30, 2023 |
1.21 Mn |
| Mar 31, 2023 |
1.50 Mn |
| Dec 31, 2022 |
909,126.00 |
| Sep 30, 2022 |
691,238.00 |
| Jun 30, 2022 |
778,268.00 |
| Mar 31, 2022 |
904,997.00 |
| Dec 31, 2021 |
890,583.00 |
| Sep 30, 2021 |
961,691.00 |
| Jun 30, 2021 |
2.27 Mn |
